Cited by 202Meta-analysis and systematic reviewsPharmaceutical industry and healthcareStatistical Methods in Clinical Trials

The DOI matches its Crossref record; 191 of the 192 references it cites were found in a registry or an index.

Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials: A Systematic Review and Meta-Analysis

Rief, Winfried, Nestoriuc, Yvonne, von Lilienfeld-Toal, Anna, Dogan, Imis, Schreiber, Franziska, Hofmann, Stefan G., Barsky, Arthur J., Avorn, Jerry·2009·Drug Safety

DOI 10.2165/11316580-000000000-00000

Open this paper in CoChat — free account

Abstract

Background Biases in adverse effect reporting in randomized controlled trials (RCTs) [e.g. due to investigator expectations or assessment quality] can be quantified by studying the rates of adverse events reported in the placebo arms of such trials.Objective We compared the rates of adverse effects reported in the placebo arms of tricyclic antidepressant (TCA) trials and placebo arms of selective serotonin reuptake inhibitor (SSRI) trials.Methods We conducted a literature search for RCTs across PUBMED, Scopus and the Cochrane Central Register of Controlled Trials (CENTRAL). Only studies allowing adverse effect analysis were included. Publication year ranged from 1981 to 2007.Results Our systematic review and meta-analysis included 143 placebocontrolled RCTs and data from 12,742 patients. Only 21% of studies used structured and systematic adverse effect ascertainment strategies. The way in which trials recorded adverse events influenced the rate of adverse effects substantially. Systematic assessment led to higher rates than less systematic assessment. Far more adverse effects were reported in TCA-placebo groups compared with SSRI-placebo groups, e.g. dry mouth (odds ratio [OR] = 3.5; 95% CI 2.9, 4.2); drowsiness (OR = 2.7; 95%CI 2.2, 3.4); constipation (OR= 2.7; 95%CI 2.1, 3.6); sexual problems (OR =2.3; 95%CI 1.5, 3.5). Regression analyses controlling for various influencing factors confirmed the results.Conclusion Adverse effect profiles reported in clinical trials are strongly influenced by expectations from investigators and patients. This difference cannot be attributed to ascertainment methods. Adverse effect patterns of the drug group are closely related to adverse effects of the placebo group. These results question the validity of the assumption that adverse effects in placebo groups reflect the 'drug-unspecific effects'.

Integrity signals

Registry

Crossref · 10.2165/11316580-000000000-00000

Cites

191 of 191 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression: Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial
(2004) · JAMA · doi:10.1001/jama.292.7.807 · Cited by 1,735
Experimenter Effects in Behavioral Research
McGuigan, F. J., & Rosenthal, R. (1968) · The American Journal of Psychology · doi:10.2307/1420816 · Cited by 1,633
Sertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109
Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder: The Pediatric OCD Treatment Study (POTS) Randomized Controlled Trial
(2004) · JAMA · doi:10.1001/jama.292.16.1969 · Cited by 1,107
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive–compulsive disorder
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048

Show all 192 references

Research works printed but not linked: 22

Cipriani, 2005, Cochrane Database Syst Rev, &NA;, CD004185
Liccardi, 2004, J Investig Allergol Clin Immunol, 14, 104
Chouinard, 1990, Psychopharmacol Bull, 26, 279
Claghorn, 1992, J Clin Psychiatry, 53, 434
Dunlop, 1990, Psychopharmacol Bull, 26, 173
Fabre, 1985 Jan, Curr Ther Res, 37, 115
Ferguson, 1994, J Clin Psychiatry, 55, 258
Geller, 1990, Psychopharmacol Bull, 26, 85
Greist, 1990, J Clin Psychiatry, 51, 292
Kasper, 2005, Am J Geriatr Psychiatry, 13, 884, 10.1097/00019442-200510000-00008 · DOI
Kiev, 1992, J Clin Psychiatry, 53, 27
Lepola, 2003 Jul, Int Clin Psychopharmacol, 18, 211, 10.1097/00004850-200307000-00003 · DOI · Paper page
Rickels, 1986 Apr, Curr Ther Res, 39, 559
Rifkin, 1985, J Clin Psychiatry, 46, 4
Smith, 1992 Feb, J Clin Psychiatry, 53, 36
Tucker, 2003, Psychopharmacol Bull, 37, 135
van der Kolk, 1994 Dec, J Clin Psychiatry, 55, 517
Wernicke, 1988, Psychopharmacol Bull, 24, 183
Wernicke, 1987, Psychopharmacol Bull, 23, 164
Amin, 1989, Psychopharmacol Bull, 25, 164
Trindade, 1998, CMAJ, 159, 1245
Justice, 1999, J Acquir Immune Defic Syndr, 21, 126

Sorted by citations

Items 101–200 of 201

Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review
Williams, M. R., McKeown, A., Pressman, Z., Hunsinger, M., Lee, K., COPLAN, P. M., Gilron, I., Katz, N. P., McDermott, M., Raja, S. N., et al. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.07.006 · Cited by 19
Physicians’ beliefs about placebo and nocebo effects in antidepressants – an online survey among German practitioners
Kampermann, L., Nestoriuc, Y., & Mora, M. C. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178719 · Cited by 18
Self-citation
Lessons to be Learned from Placebo Arms in Psychopharmacology Trials
Doering, B. K., Rief, W., & Petrie, K. J. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_15 · Cited by 18
Self-citation
Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data
Allen, E. N., Chandler, C., Mandimika, N., Pace, C., Mehta, U., & Barnes, K. I. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-325 · Cited by 17
Nocebo effects: more investigation is needed
Benedetti, F., & Shaibani, A. I. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1474199 · Cited by 17
Comparative efficacy and acceptability of psychotherapeutic, pharmacological, and combination treatments for non-suicidal self-injury in children and adolescents: a systematic review and network meta-analysis
Chen, X., Dong, Y., Ye, M., Wang, X., Yan, J., Yao, Y., Zhou, Q., Qian, C., & Liu, Z. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06735-1 · Cited by 17
Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials?
Amanzio, M. (2010) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488911794079109 · Cited by 16
Placebo Analgesia From a Rubber Hand
Coleshill, M. J., George, D. N., & Mazzoni, G. A. L. (2017) · Journal of Pain · doi:10.1016/j.jpain.2017.04.004 · Cited by 16
Alternative package leaflets improve people’s understanding of drug side effects—A randomized controlled exploratory survey
Mühlbauer, V., Prinz, R., Mühlhauser, I., & Wegwarth, O. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203800 · Cited by 16
Placebo-related effects: a meta-narrative review of conceptualization, mechanisms and their relevance in rheumatology
Coste, J., & Montel, S. (2016) · Rheumatology · doi:10.1093/rheumatology/kew274 · Cited by 16
Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study
Meißner, K., Talsky, N., Olliges, E., Jacob, C., Stötzer, O. J., Salat, C., Braun, M., & Flondor, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00410 · Cited by 15
Improving Medication Tolerance
Ballou, S., Iturrino, J., Rangan, V., Cheng, V., Kelley, J. M., Lembo, A. J., Kaptchuk, T. J., & Nee, J. W. (2021) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001575 · Cited by 15
How to Handle Worsening of Condition during Treatment - Risk Assessment in Homeopathic Practice
Stub, T., Salamonsen, A., Kristoffersen, A. E., & Musial, F. (2015) · Complementary Medicine Research · doi:10.1159/000377644 · Cited by 15
It is not just the drugs that matter: the nocebo effect
Wojtukiewicz, M. Z., Polityńska, B., Skalij, P., Tokajuk, P., Wojtukiewicz, A. M., & Honn, K. V. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09800-w · Cited by 15
Clinically meaningful nocebo effect occurs in acupuncture treatment: a systematic review
Koog, Y. H., Lee, J. S., & Wi, H. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.02.021 · Cited by 14
Lessons Learned From Nocebo Effects in Clinical Trials for Pain Conditions and Neurodegenerative Disorders
Amanzio, M., Palermo, S., Skyt, I., & Vase, L. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000556 · Cited by 15
Hypothalamic‐Pituitary‐Adrenal Activity in Adverse Events Reporting After Placebo Administration
Benedetti, F., Amanzio, M., Giovannelli, F., Craigs‐Brackhahn, K., & Shaibani, A. I. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2388 · Cited by 12
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting
Panariello, F., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Ferentinos, P., Rujescu, D., Mendlewicz, J., Ronchi, D. D., Serretti, A., et al. (2022) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2134588 · Cited by 13
Homeopathic drug proving of Okoubaka aubrevillei: a randomised placebo-controlled trial
Teut, M., Dahler, J., Hirschberg, U., Lüdtke, R., Albrecht, H., & Witt, C. M. (2013) · Trials · doi:10.1186/1745-6215-14-96 · Cited by 12
Evaluating molecular fingerprint-based models of drug side effects against a statistical control
Alpay, B. A., Gosink, M. M., & Aguiar, D. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103364 · Cited by 11
Placebo effect and therapeutic context: A challenge in clinical research
Morral, A., Urrútia, G., & Bonfill, X. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2017.06.010 · Cited by 14
Nocebo effects and psychotropic drug action
Amanzio, M. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.992877 · Cited by 13
Reporting of adverse events and statistical details of efficacy estimates in randomized clinical trials of pain in temporomandibular disorders
Gewandter, J. S., Smith, S. M., McKeown, A., Edwards, K., Narula, A., Pawlowski, J. R., Rothstein, D., Desjardins, P. J., Dworkin, S. F., Gross, R. A., et al. (2015) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2014.12.023 · Cited by 12
Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone
Yuen, K. C. J., Moraitis, A. G., & Nguyen, D. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1097 · Cited by 11
Beliefs About Medicines Predict Side-Effects of Placebo Modafinil
Heller, M. K., Chapman, S., & Horne, R. (2022) · Annals of Behavioral Medicine · doi:10.1093/abm/kaab112 · Cited by 7
Orally administered whole egg demonstrates antidepressant-like effects in the forced swimming test on rats
Nagasawa, M., Otsuka, T., Ogino, Y., Yoshida, J., Tomonaga, S., Yasuo, S., & Furuse, M. (2013) · Acta Neuropsychiatrica · doi:10.1017/neu.2013.56 · Cited by 10
Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial
Meißner, C., Warren, C. V., Fadai, T., Müller, A., Zapf, A., Lezius, S., Ozga, A., Falkenberg, I., Kircher, T. T. J., & Nestoriuc, Y. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04941-3 · Cited by 11
Self-citation
Preanesthetic nurse communication with children and parents—an observational study
Perry, C., Samuelsson, C., & Cyna, A. M. (2015) · Pediatric Anesthesia · doi:10.1111/pan.12759 · Cited by 10
Nonspecific Adverse Events in Knee Osteoarthritis Clinical Trials: A Systematic Review
Koog, Y. H., Lee, J. S., & Wi, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111776 · Cited by 9
Nocebo as a source of bias in the assessment of treatment effect
Wartolowska, K. A. (2019) · F1000Research · doi:10.12688/f1000research.17611.1 · Cited by 25
Erwartungseffekte beim Absetzen von Antidepressiva
Nestoriuc, Y. (2022) · Psychotherapeut · doi:10.1007/s00278-022-00587-w · Cited by 9
Self-citation
Avoidance of nocebo effects by coincident naming of treatment benefits during the medical interview for informed consent—Evidence from dynamometry
Zech, N., Schrödinger, M., & Hansen, E. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.923044 · Cited by 10
Placeboeffekte in der Schmerztherapie
Kunkel, A., & Bingel, U. (2023) · Der Schmerz · doi:10.1007/s00482-022-00685-3 · Cited by 9
Joint Modeling of Efficacy, Dropout, and Tolerability in Flexible-Dose Trials: A Case Study in Depression
Russu, A., Marostica, E., Nicolao, G. D., Hooker, A. C., Poggesi, I., Goméni, R., & Zamuner, S. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.322 · Cited by 9
Significance of Participants’ Expectations in Managing the Placebo Effect in Antidepressant Research
Ćurković, M., & Košec, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00713 · Cited by 9
Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis
Mostafaei, H., Mori, K., Quhal, F., Miura, N., Motlagh, R. S., Pradère, B., Laukhtina, E., Lysenko, I., Ghaffari, S., Hajebrahimi, S., et al. (2020) · European Urology Focus · doi:10.1016/j.euf.2020.10.010 · Cited by 9
Adverse events reported by anxious school refusing adolescents receiving cognitive behavioral therapy with and without fluoxetine
Melvin, G. A., Finnin, L., Taffe, J. R., Dudley, A. L., Klimkeit, E., Gordon, M. S., & Tonge, B. J. (2019) · Clinical Child Psychology and Psychiatry · doi:10.1177/1359104518822681 · Cited by 9
Meta-analysis as the core of evidence-based behavioral medicine: tools and pitfalls of a statistical approach
Nestoriuc, Y., Kriston, L., & Rief, W. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328336666b · Cited by 8
Self-citation
Treatment-Resistant Depression
Cusin, C., & Peyda, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-97241-1_1 · Cited by 8
What helps, what hinders antidepressant discontinuation? Qualitative analysis of patients’ experiences and expectations
Meißner, C., Meyrose, A., & Nestoriuc, Y. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2023.0020 · Cited by 9
Self-citation
Are They Side Effects? Extraintestinal Symptoms Reported During Clinical Trials of Irritable Bowel Syndrome May Be More Severe at Baseline
Ballou, S., Hassan, R., Nee, J. W., Iturrino, J., Rangan, V., Cheng, V., Conboy, L. A., Kirsch, I., Lembo, A. J., Kaptchuk, T. J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.03.018 · Cited by 7
The impact of chronic imipramine treatment on amino acid concentrations in the hippocampus of mice
Nagasawa, M., Murakami, T., Tomonaga, S., & Furuse, M. (2012) · Nutritional Neuroscience · doi:10.1179/1476830512y.0000000015 · Cited by 7
Placebo Harm
Edwards, I. R., Graedon, J., & Graedon, T. (2010) · Drug Safety · doi:10.2165/11532400-000000000-00000 · Cited by 7
Negative expectations (nocebo phenomenon) in clinical interventions: A scoping review
Nasiri‐Dehsorkhi, H., Vaziri, S., Esmaillzadeh, A., & Adibi, P. (2024) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_269_23 · Cited by 7
Examining the Nocebo Effect in Trials of Neuromodulators for Use in Disorders of Gut-Brain Interaction
Brown, J. R. G., Sanayei, A. M., Proctor, S., Flanagan, R. F., Ballou, S., Bain, P. A., & Nee, J. W. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002108 · Cited by 6
Placebo and nocebo effects and their significance in clinical practice
Klarić, M., Mandić, V., Lovrić, S., Ćorić, M. K., & Zovko, N. (2016) · Medicinski Glasnik · doi:10.17392/892-16 · Cited by 6
Involvement of proBDNF in Monocytes/Macrophages with Gastrointestinal Disorders in Depressive Mice
Yu, Y.-Q., Zhang, Y., Wang, Z., Liu, Y., Li, H., Zhou, X., Hu, Z., & Dai, R. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00235-8 · Cited by 6
Individual difference factors that predict evaluations and acceptance of authorized concealment for the reduction of nocebo side effects
Spotts, E. K., Miller, F. G., & Geers, A. L. (2025) · Patient Education and Counseling · doi:10.1016/j.pec.2025.108676 · Cited by 4
Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics
Levy, A., El‐Hage, W., Bennabi, D., Allauze, E., Bouvard, A., Camus, V., Courtet, P., Dorey, J., Étain, B., Fond, G. B., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.795666 · Cited by 7
Negative Effects During Placebo Treatment
Bschor, T., Unger, J., Nagel, L., Schwarzer, G., & Baethge, C. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0336 · Cited by 5
Pooled analysis of adverse event collection from 4 acute coronary syndrome trials
Zimerman, A., Lópes, R. D., Stebbins, A., Guimarães, P. O., Haque, G., Melloni, C., Trollinger, K. M., James, S. K., Alexander, J. H., Tricoci, P., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.01.003 · Cited by 5
Advances in the pharmacotherapeutic management of post-traumatic stress disorder
Akhtar, A., & Sah, S. P. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1935871 · Cited by 5
A New Paradigm Shift in Antidepressant Therapy: From Dual-action to Multitarget-directed Ligands
Rodríguez-Lavado, J., Alarcón‐Espósito, J., Mallea, M., & Lorente, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220317121551 · Cited by 5
Lessons to be learned from placebo groups in clinical trials
Rief, W. (2011) · Pain · doi:10.1016/j.pain.2011.03.007 · Cited by 5
Self-citation
Was kann die Psychotherapie vom Placeboeffekt lernen?
Rief, W. (2022) · Psychotherapeut · doi:10.1007/s00278-022-00586-x · Cited by 5
Self-citation
Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies
Giovannelli, F., Zaccara, G., Cincotta, M., Loiacono, G., & Verrotti, A. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7535-0 · Cited by 4
De-risking in Tier I CNS safety assessments is the primary function of study design and technical training of laboratory staff observers
Gauvin, D. V., Zimmermann, Z. J., & Dalton, J. A. (2022) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2022.105116 · Cited by 4
The need to investigate nocebo effects in more detail
Benedetti, F., Frisaldi, E., & Piedimonte, A. (2019) · World Psychiatry · doi:10.1002/wps.20627 · Cited by 4
Nocebo effects and psychotropic drug action - an update
Amanzio, M., & Palermo, S. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1722100 · Cited by 4
Schmerzbehandlung bei Menschen mit Demenz
Schüler, M. (2019) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-019-01578-4 · Cited by 3
Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]
Müller, A., Konigorski, S., Meißner, C., Fadai, T., Warren, C. V., Falkenberg, I., Kircher, T. T. J., & Nestoriuc, Y. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05184-y · Cited by 4
Self-citation
Generalization and enhancement of the effects of an active placebo nasal spray on sadness
Wilhelm, M., Fischer, S. M., Rief, W., Fiorio, M., & Barbiani, D. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.045 · Cited by 3
Self-citation
Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double‐blind, crossover trial
Cornell, J. L., Conchas, A., Wang, X., Fink, J. C., Chen, H., Kane, M. A., Pilli, N. R., Ait‐Daoud, N., Gorelick, D. A., Li, M. D., et al. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14931 · Cited by 3
Patient perspectives of positive messages from clinicians: a qualitative secondary analysis and conceptual model
Dean, S., Ivynian, S. E., Howick, J., & Levett-Jones, T. L. (2023) · Contemporary Nurse · doi:10.1080/10376178.2023.2175701 · Cited by 3
Mental Health Interventions for the Elderly
Mikesell, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-12852-4_8-1 · Cited by 3
Influence of Placebo Analgesia in Pharmacological Treatment of Pain
Sanders, D., Colloca, L., & Finniss, D. G. (2020) · Future Drug Discovery · doi:10.4155/fdd-2019-0028 · Cited by 2
Association Between Sexual Dysfunction and Dose of Atypical Antipsychotics: Essential to Learn the Basics
Krishnegowda, S., Udaykumar, P., & Yadiyal, A. (2022) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2131 · Cited by 2
Placeboeffekte bei der Therapie mit Antidepressiva
Rief, W., & Κube, T. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01784-5 · Cited by 2
Self-citation
The Dark Side of Body Sensations
Köteles, F. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-63201-4_9 · Cited by 2
The Placebo and Nocebo Effects in Cancer Treatment
Schuricht, F., & Nestoriuc, Y. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4866-2_18 · Cited by 2
Self-citation
Sexual functioning in depression
Grover, S., & Sahoo, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00047-7 · Cited by 1
Placebo effects in mental disorders
Wilhelm, M., Rief, W., & Salzmann, S. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-29884-4.00016-9 · Cited by 1
Self-citation
Case Report: Severe SIADH and QTc prolongation induced by escitalopram-quetiapine interaction in a CYP2C19 intermediate metabolizer at therapeutic doses
蒋宗辰, Qu, X., Yan, Z., Fang, J., Lan, J., Zhao, X., & Qi, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1776959 · Cited by 1
Safety and Tolerability of Antidepressants
Manson, C., Gordon, R., & Baldwin, D. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-24741-0_8 · Cited by 1
Safety of treatment provided by homeopaths
Stub, T., Salamonsen, A., & Alræk, T. (2016) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2016.08.074 · Cited by 1
Zsigeri fájdalom, nocebo-hatások, placebo-analgézia
Bárdos, G. (2021) · Scientia et Securitas · doi:10.1556/112.2021.00033 · Cited by 1
The Unintended Consequences of Adverse Event Information on Medicines’ Risks and Label Content
Furlan, G., & Power, D. (2020) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00367-4 · Cited by 1
Can We Say No to the ‘Nocebo Effect’ in Inflammatory Bowel Diseases?
Gönczi, L., & Lakatos, P. L. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz098 · Cited by 1
The Role of Response Expectancies in Neuropsychological Performance in Young Adults Concerned about Attention-Deficit/Hyperactivity Disorder
Wei, C. C. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
Neurobiologie der Plazebowirkung
Müller, M. J. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_52
L'effet nocebo : étude préliminaire descriptive chez des patients hospitalisés en néphrologie
Planès, S. (2014) · HAL
Effekte, Bedingungen und Anwendung von Placebos
Werner, C., Hasler, S., Birkhäuer, J., & Gaab, J. (2016) · PSYCH up2date · doi:10.1055/s-0042-100680
The Ills of Health
Justman, S. (2015) · Palgrave Macmillan US eBooks · doi:10.1057/9781137523297_2
The role of cognitive impairment in the placebo and nocebo effects
Amanzio, M. (2016) · Wiley eBooks · doi:10.1002/9781118455968.ch16
Searching for Signs
Justman, S. (2015) · Palgrave Macmillan US eBooks · doi:10.1057/9781137523297_3
Die Beeinflussung des instrumentellen Lernens durch Placebo- und Noceboeffekte
Gunkel, L. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6431
Current awareness: Pharmacoepidemiology and drug safety
(2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1850
Placebo Effect
Benedetti, F., & Piedimonte, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_197
Nocebo Effects from COVID-19 and Vaccination Hesitancy
Lin, C.-H. (2021) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_33_21
Placebo Effect
Benedetti, F., & Piedimonte, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-21573-6_197-1
Influence on study outcomes of an inpatient study by the behavior of the study staff (PINgPOng): study protocol for a randomized clinical trial
Coenen, M., Bingel, U., Zunhammer, M., Berdaguer, M. S., Fuhrmann, C., Fimmers, R., Rengelshausen, J., Hartmann, G., Schedlowski, M., & Coch, C. (2022) · Trials · doi:10.1186/s13063-022-06436-0 · Cited by 1
Postakute Effekte von klassischen Psychedelika
Evens, R., & Majić, T. (2024) · Nervenheilkunde · doi:10.1055/a-2305-6591
Antidepressants and ocular health: Addressing dry eye syndrome
Mansoor, A., Mansoor, S., & Khan, A. (2024) · Journal of Shifa Tameer-e-Millat University · doi:10.32593/jstmu/vol7.iss1.249
Allergy-like nocebo events reported with COVID-19 vaccines: a case control study
Brès, V., Fadhel, N. B., Trouillet, R., Broc, G., Chiriac, A. M., & Faillie, J. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2497397
Additional file 1 of Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial
Meißner, C., Warren, C. V., Fadai, T., Müller, A., Zapf, A., Lezius, S., Ozga, A.-K., Falkenberg, I., Kircher, T., & Nestoriuc, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26598848
Self-citation
Additional file 2 of Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]
Müller, A., Konigorski, S., Meißner, C., Fadai, T., Warren, C. V., Falkenberg, I., Kircher, T., & Nestoriuc, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26626822
Self-citation
Additional file 2 of Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial
Meißner, C., Warren, C. V., Fadai, T., Müller, A., Zapf, A., Lezius, S., Ozga, A.-K., Falkenberg, I., Kircher, T., & Nestoriuc, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26598851
Self-citation
Additional file 1 of Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]
Müller, A., Konigorski, S., Meißner, C., Fadai, T., Warren, C. V., Falkenberg, I., Kircher, T., & Nestoriuc, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26626819
Self-citation
Self-reported antidepressant side effects in psychiatric patients with depressive disorders
von Knorring, J., Baryshnikov, I., Jylhä, P., Talaslahti, T., & Isometsä, E. (2026) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2026.2686197
Does Adding Nocebo Avoidance Strategies Increase the Strength of Nocebo Education?
Spotts, E. K., & Geers, A. L. (2026) · European Journal of Health Psychology · doi:10.1027/2512-8442/a000207

Authors: Rief, W., Nestoriuc, Y., von Lilienfeld-Toal, A., Dogan, I., Schreiber, F., Hofmann, S. G., Barsky, A. J., & Avorn, J.
Affiliations: Philipps University of Marburg (DE)
Boston University (US)
Brigham and Women's Hospital (US)
Corresponding author: Rief, Winfried
ORCID: Rief, Winfried
Nestoriuc, Yvonne
Dogan, Imis
Schreiber, Franziska
Hofmann, Stefan G.
Avorn, Jerry
Venue: Drug Safety
Publisher: Springer Science and Business Media LLC
Published: 2009-11
Volume: 32
Issue: 11
Pages: 1041-1056
ISSN: 0114-5916 (ISSN-L)
DOI: 10.2165/11316580-000000000-00000
OpenAlex: W59643826
Semantic Scholar: 50b250c59bddc89685a35b4cffa7ab9cf1b7a1e4
Cited by: 202
References: 192
Citations by year: 2026: 3 · 2025: 6 · 2024: 11 · 2023: 6 · 2022: 15 · 2021: 14 · 2020: 12 · 2019: 18 · 2018: 16 · 2017: 11 · 2016: 17 · 2015: 15 · 2014: 16 · 2013: 11 · 2012: 16
FWCI: 12.82
Type: journal article
Language: en
Open access: closed
Locations: Drug Safety (publishedVersion)
PubMed (publishedVersion)
Radboud Repository (Radboud University) (submittedVersion)
Topics: Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords: placebo group, selective serotonin reuptake inhibitors, tricyclic antidepressants, investigator bias, xerostomia, sleepiness, constipation, sexual dysfunction, antidepressant trials
MeSH terms: Antidepressive Agents, Tricyclic, Humans, Regression Analysis, Research Personnel, Bias, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation, Research Subjects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials: A Systematic Review and Meta-Analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks